Synthomer (LON:SYNT) Given New GBX 230 Price Target at Berenberg Bank

Synthomer (LON:SYNTFree Report) had its price objective reduced by Berenberg Bank from GBX 265 ($3.32) to GBX 230 ($2.88) in a research report sent to investors on Monday,Digital Look reports. Berenberg Bank currently has a buy rating on the stock.

Separately, Canaccord Genuity Group cut their price target on Synthomer from GBX 300 ($3.75) to GBX 275 ($3.44) and set a “buy” rating for the company in a research note on Friday, October 4th.

Read Our Latest Report on SYNT

Synthomer Stock Down 7.5 %

LON SYNT traded down GBX 11.40 ($0.14) during trading hours on Monday, hitting GBX 140 ($1.75). 973,343 shares of the company traded hands, compared to its average volume of 427,960. The stock has a market capitalization of £229.00 million, a price-to-earnings ratio of -229.51, a P/E/G ratio of -0.17 and a beta of 1.79. Synthomer has a twelve month low of GBX 118 ($1.48) and a twelve month high of GBX 338 ($4.23). The business’s 50-day moving average is GBX 168.03 and its 200-day moving average is GBX 210.77. The company has a debt-to-equity ratio of 77.42, a quick ratio of 0.97 and a current ratio of 1.90.

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

Further Reading

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.